当前位置： SCI文献检索 > ONCOGENE期刊下所有文献 > Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.

Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.

Abstract：

:Constitutive activation of the JAK/STAT3 pathway is a major contributor to oncogenesis. In the present study, structure-activity relationship (SAR) studies with five cucurbitacin (Cuc) analogs, A, B, E, I, and Q, led to the discovery of Cuc Q, which inhibits the activation of STAT3 but not JAK2; Cuc A which inhibits JAK2 but not STAT3 activation; and Cuc B, E, and I, which inhibit the activation of both. Furthermore, these SAR studies demonstrated that conversion of the C3 carbonyl of the cucurbitacins to a hydroxyl results in loss of anti-JAK2 activity, whereas addition of a hydroxyl group to C11 of the cucurbitacins results in loss of anti-STAT3 activity. Cuc Q inhibits selectively the activation of STAT3 and induces apoptosis without inhibition of JAK2, Src, Akt, Erk, or JNK activation. Furthermore, Cuc Q induces apoptosis more potently in human and murine tumors that contain constitutively activated STAT3 (i.e., A549, MDA-MB-435, and v-Src/NIH 3T3) as compared to those that do not (i.e., H-Ras/NIH 3T3, MDA-MB-453, and NIH 3T3 cells). Finally, in a nude mouse tumor xenograft model, Cuc Q, but not Cuc A, suppresses tumor growth indicating that JAK2 inhibition is not sufficient to inhibit tumor growth and suggesting that the ability of Cuc Q to inhibit tumor growth is related to its anti-STAT3 activity. These studies further validate STAT3 as a drug discovery target and provide evidence that pharmacological agents that can selectively reduce the P-STAT3 levels in human cancer cells result in tumor apoptosis and growth inhibition.

journal_name

Oncogene

journal_title

Oncogene

authors

Sun J,Blaskovich MA,Jove R,Livingston SK,Coppola D,Sebti SM

doi

10.1038/sj.onc.1208470

subject

Has Abstract

pub_date

2005-05-05 00:00:00

pages

3236-45

issue

20

eissn

0950-9232

issn

1476-5594

pii

1208470

journal_volume

24

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.

    abstract：:Activating mutations of K-ras are frequent in colon tumors and aberrant crypt foci, and may play important roles in colon carcinogenesis. Here, we investigated the effects of a K-ras codon 12 mutation on inducible nitric oxide synthase (iNOS) expression. When rat intestinal epithelial cells (IEC-6) were transfected wi...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1207051

    authors： Takahashi M,Mutoh M,Shoji Y,Kamanaka Y,Naka M,Maruyama T,Sugimura T,Wakabayashi K

    更新日期：2003-10-23 00:00:00

  • C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.

    abstract：:CCAAT/enhancer-binding protein-δ (C/EBP-δ), a transcription factor, is elevated in carcinoma compared with that in normal tissue. This study reports a novel function of C/EBP-δ in lymphangiogenesis and tumor metastasis. Genetic deletion of C/EBP-δ in mice resulted in a significant reduction of lymphangiogenesis and pu...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2011.187

    authors： Min Y,Ghose S,Boelte K,Li J,Yang L,Lin PC

    更新日期：2011-12-08 00:00:00

  • New insights into apoptosis signaling by Apo2L/TRAIL.

    abstract：:Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/onc.2010.221

    authors： Gonzalvez F,Ashkenazi A

    更新日期：2010-08-26 00:00:00

  • ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.

    abstract：:We have recently identified ZNF185 as a gene that is downregulated in prostate cancer (PCa), in part via epigenetic alteration, and maybe associated with disease progression. In this study, we cloned the ZNF185 cDNA from normal human prostate tissues and investigated its biological function. We show that ZNF185 is a n...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1209769

    authors： Zhang JS,Gong A,Young CY

    更新日期：2007-01-04 00:00:00

  • SLUG in cancer development.

    abstract：:The SNAIL-related zinc-finger transcription factor, SLUG (SNAI2), is critical for the normal development of neural crest-derived cells and loss-of-function SLUG mutations have been proven to contribute to piebaldism and Waardenburg syndrome type 2 in a dose-dependent fashion. While aberrant induction of SLUG has been ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208505

    authors： Pérez-Mancera PA,González-Herrero I,Pérez-Caro M,Gutiérrez-Cianca N,Flores T,Gutiérrez-Adán A,Pintado B,Sánchez-Martín M,Sánchez-García I

    更新日期：2005-04-28 00:00:00

  • The cyclin-dependent kinase inhibitor p27Kip1 is localized to the cytosol in Swiss/3T3 cells.

    abstract：:p27Kip1 plays an important role in cell cycle progression by negatively regulating the activity of cyclin-Cdk complexes. To understand how p27Kip1 functions, the level and subcellular location of p27Kip1 in Swiss/3T3 cells following serum stimulation of quiescent cells was examined. Surprisingly, p27Kip1 was observed ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1202912

    authors： Wang G,Miskimins R,Miskimins WK

    更新日期：1999-09-16 00:00:00

  • Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.

    abstract：:E mu-bcl-2 transgenic mice bearing the bcl-2 proto-oncogene linked to the immunoglobulin enhancer (E mu) sporadically develop B or T cell lymphomas after a long latent period. To identify genes that play important roles in development of lymphoid malignancies, proviral insertional mutagenesis with Moloney murine leuke...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Shinto Y,Morimoto M,Katsumata M,Uchida A,Aozasa K,Okamoto M,Kurosawa T,Ochi T,Greene MI,Tsujimoto Y

    更新日期：1995-11-02 00:00:00

  • Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.

    abstract：:The LoVo colon carcinoma cell line that presents two wild type p53 alleles was used as the recipient for a series of transfections with p53 expression vectors coding for wild-type or three different mutants (143ala, 175his or 273his). The parental cell line as well as all clones that had rearranged the plasmid with co...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Pocard M,Chevillard S,Villaudy J,Poupon MF,Dutrillaux B,Remvikos Y

    更新日期：1996-02-15 00:00:00

  • Molecular interdiction of Src-family kinase signaling in hematopoietic cells.

    abstract：:The ability of Src-family kinases (SFKs) to mediate signaling from cell surface receptors in hematopoietic cells is a function of their catalytic activity, location and binding partners. Kinase activity is regulated in the cell by kinases and phosphatases that alter the state of phosphorylation of key tyrosine residue...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/sj.onc.1208078

    authors： Geahlen RL,Handley MD,Harrison ML

    更新日期：2004-10-18 00:00:00

  • The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.

    abstract：:The DCC (deleted in colorectal cancer) gene was originally identified as a candidate tumour suppressor gene in colon carcinogenesis on the basis of allelic losses in chromosome 18q.21 in 70% of colon cancers. Reverse transcriptase polymerase chain reaction (RT-PCR) of DCC mRNA suggests that DCC expression may also be ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Gotley DC,Reeder JA,Fawcett J,Walsh MD,Bates P,Simmons DL,Antalis TM

    更新日期：1996-08-15 00:00:00

  • Isolation of two novel ras genes in Dictyostelium discoideum; evidence for a complex, developmentally regulated ras gene subfamily.

    abstract：:In Dictyostelium discoideum, three ras genes (rasD, rasG and rasB) and one ras-related gene (rap1) have been previously isolated and characterized, and the deduced amino acid sequence of their predicted protein products share at least 50% sequence identity with the human H-Ras protein. We have now cloned and character...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Daniel J,Bush J,Cardelli J,Spiegelman GB,Weeks G

    更新日期：1994-02-01 00:00:00

  • Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor.

    abstract：:Numerous reports suggest that use of nonsteroidal anti-inflammatory drugs (NSAIDs) decrease mortality from colorectal cancer. To better understand all of the mechanisms underlying this effect, the global pattern of gene expression in colon carcinoma cells following treatment with NS-398, a selective cyclo-oxygenase-2 ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1204588

    authors： Zhang Z,DuBois RN

    更新日期：2001-07-27 00:00:00

  • Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).

    abstract：:To understand the mechanism of interferon (IFN)-mediated suppression of cell cycle progression, we have earlier shown that IFN-alpha enhances the expression of underphosphorylated retinoblastoma protein by inhibiting the cyclin-dependent kinase-2 (CDK-2) activity (Kumar and Atlas, Proc. Natl. Acad. Sci. 89, 6599-6603,...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201529

    authors： Mandal M,Bandyopadhyay D,Goepfert TM,Kumar R

    更新日期：1998-01-15 00:00:00

  • p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex.

    abstract：:The mechanisms involved in the p53-dependent control of gene expression following DNA damage have not been completely elucidated. Here, we show that the p53 C terminus associates with factors that are required for the ultraviolet (UV)-induced inhibition of the mRNA 3' cleavage step of the polyadenylation reaction, suc...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2011.29

    authors： Nazeer FI,Devany E,Mohammed S,Fonseca D,Akukwe B,Taveras C,Kleiman FE

    更新日期：2011-07-07 00:00:00

  • MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.

    abstract：:Malignant tumors are exemplified by excessive proliferation and aggressive migration/invasion contributing to increased mortality of cancer patients. Matrix metalloproteinase 9 (MMP9) expression is positively correlated with lung cancer malignancy. The mechanism underlying an elevated MMP9 expression is not clearly de...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2015.14

    authors： Cheng X,Yang Y,Fan Z,Yu L,Bai H,Zhou B,Wu X,Xu H,Fang M,Shen A,Chen Q,Xu Y

    更新日期：2015-10-29 00:00:00

  • Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.

    abstract：:Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1208325

    authors： May D,Itin A,Gal O,Kalinski H,Feinstein E,Keshet E

    更新日期：2005-02-03 00:00:00

  • Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.

    abstract：:The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA me...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1209272

    authors： Suzuki M,Yamada T,Kihara-Negishi F,Sakurai T,Hara E,Tenen DG,Hozumi N,Oikawa T

    更新日期：2006-04-20 00:00:00

  • Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.

    abstract：:Our recent study showed critical roles of Dmp1 as a sensor of oncogenic Ras, HER2/neu signaling and activation of the Arf-p53 pathway. To elucidate the role of human DMP1 (hDMP1) in breast cancer, one hundred and ten pairs of human breast cancer specimen were studied for the alterations of the hDMP1-ARF-Hdm2-p53 pathw...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.423

    authors： Maglic D,Zhu S,Fry EA,Taneja P,Kai F,Kendig RD,Sugiyama T,Miller LD,Willingham MC,Inoue K

    更新日期：2013-08-29 00:00:00

  • How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

    abstract：:Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-...

    journal_title：Oncogene

    pub_type： 杂志文章,评审

    doi：10.1038/onc.2014.320

    authors： Lincet H,Icard P

    更新日期：2015-07-01 00:00:00

  • Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells.

    abstract：:Apoptosis resistance is crucially involved in cancer development and progression, represents the leading cause for failure of anticancer therapy and is caused, for example, by downregulation of proapoptotic intracellular signaling molecules such as caspase-8. We found that the cytotoxic drugs methotrexate (MTX) and 5-...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210666

    authors： Ehrhardt H,Häcker S,Wittmann S,Maurer M,Borkhardt A,Toloczko A,Debatin KM,Fulda S,Jeremias I

    更新日期：2008-01-31 00:00:00

  • Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.

    abstract：:The heterodimeric nuclear factor (NF) 90/NF45 complex (NF90/NF45) binds nucleic acids and is a multifunctional regulator of gene expression. Here we report that depletion of NF90/NF45 restores the expression of the p53 and p21 proteins in cervical carcinoma cells infected with high-risk human papillomaviruses (HPVs). ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2012.533

    authors： Shamanna RA,Hoque M,Pe'ery T,Mathews MB

    更新日期：2013-10-24 00:00:00

  • Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.

    abstract：:The SCL/TAL1 gene was originally identified by virtue of its rearrangement and transcriptional activation in patients with T cell acute lymphoblastic leukaemia. It encodes a helix-loop-helix transcription factor, is not normally expressed in T cells, but is expressed in erythroid, mast, megakaryocytic and progenitor c...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Murrell AM,Bockamp EO,Göttgens B,Chan YS,Cross MA,Heyworth CM,Green AR

    更新日期：1995-07-06 00:00:00

  • Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.

    abstract：:The RAF-mitogen-activated protein kinase kinase 1/2-extracellular signal-regulated kinase 1/2 (RAF-MEK1/2-ERK1/2) pathway is activated in many human tumours and can protect cells against growth factor deprivation; however, most such studies have relied upon overexpression of RAF or MEK constructs that are not found in...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/onc.2008.335

    authors： Wickenden JA,Jin H,Johnson M,Gillings AS,Newson C,Austin M,Chell SD,Balmanno K,Pritchard CA,Cook SJ

    更新日期：2008-12-04 00:00:00

  • Isolation of a gene encoding a novel receptor tyrosine kinase from differentiated embryonic stem cells.

    abstract：:A mouse gene encoding a receptor tyrosine kinase, designated Embryonic receptor kinase (EmRK2), was isolated from embryoid bodies (EBs) generated by differentiating embryonic stem (ES) cells in culture for 6 days. Sequence analysis of EmRK2 cDNA clones predicts a receptor with a 755 amino acid extracellular region wit...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Choi K,Wall C,Hanratty R,Keller G

    更新日期：1994-04-01 00:00:00

  • Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.

    abstract：:We have identified the mouse telomerase reverse transcriptase component (mTERT) and demonstrate both substantial sequence homology to the human ortholog (hTERT), and the presence of reverse transcriptase and telomerase specific motifs. Furthermore, we show functional interchangeability with hTERT in in vitro telomeras...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1201933

    authors： Greenberg RA,Allsopp RC,Chin L,Morin GB,DePinho RA

    更新日期：1998-04-02 00:00:00

  • Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.

    abstract：:BRCA1 mutation carriers have an 85% lifetime risk of breast cancer and 60% for ovarian cancer. BRCA1 facilitates DNA double-strand break repair, and dysfunction of BRCA1 leads to hypersensitivity to DNA damaging agents and consequently genomic instability of cells. In this communication, we have examined the tumor inc...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1210451

    authors： Jeng YM,Cai-Ng S,Li A,Furuta S,Chew H,Chen PL,Lee EY,Lee WH

    更新日期：2007-09-13 00:00:00

  • Identification of RASSF8 as a candidate lung tumor suppressor gene.

    abstract：:The RASSF8 gene, which maps close to the KRAS2 gene, contains a RAS-associated domain and encodes a protein that is evolutionarily conserved from fish to humans. Analysis of the RASSF8 transcript revealed a complex expression pattern of 5'-UTR mRNA isoforms in normal lung and in lung adenocarcinomas (ADCAs), with no a...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：10.1038/sj.onc.1209422

    authors： Falvella FS,Manenti G,Spinola M,Pignatiello C,Conti B,Pastorino U,Dragani TA

    更新日期：2006-06-29 00:00:00

  • Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.

    abstract：:We have characterized a chromosomal translocation in a cell line (SU-DUL5) established from a patient with lymphoblastic lymphoma in which the c-myc gene on chromosome 8 was juxtaposed to a t(14;18). Cytogenetic analysis of this cell line showed 14q+, 18q-, and 8p+q+ marker chromosomes in the absence of t(14;18). Geno...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Kiem HP,Nourse J,Saltman DL,Blume KG,Cleary ML

    更新日期：1990-12-01 00:00:00

  • Retroviral heterogeneity in mouse lymphomas.

    abstract：:Provirus modifications which can occur in tumors may lead to tumor antigenic variants. To investigate this possibility we compared the restriction fragment length patterns of mouse mammary tumor virus (MMTV), murine leukemia virus and xenotropic and mink cell-focus inducing (MCF)-related sequences, using Southern blot...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Colombo MP,Ferrari G,Parmiani G,Wettstein PJ

    更新日期：1988-04-01 00:00:00

  • The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.

    abstract：:The E6 proteins of specific cancer-associated human papillomaviruses (HPVs) complex with and mediate degradation of the cellular anti-oncogene p53 in vitro. A critical property of p53 is its ability to stimulate transcription from promoters containing its recognition sequence. HPV E6, mutant p53 proteins, and several ...

    journal_title：Oncogene

    pub_type： 杂志文章

    doi：

    authors： Mansur CP,Marcus B,Dalal S,Androphy EJ

    更新日期：1995-02-02 00:00:00